Financials

  • Market Capitalization 1.66 B
  • Employee 325
  • Founded 2006
  • CEO Pravin Dugel
  • Website www.ocutx.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BZV0
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-8.55
Rapporto prezzo/fatturato
43.75

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2051
ZBIO
Zenas BioPharma, Inc. - Common Stock
26.40 USD-3.15%-5.27%-14.84%-0.23%1.72 B USD
2060
GPCR
Structure Therapeutics Inc - American Depositary Shares
23.91 USD-6.38%-13.21%-38.57%-10.58%1.71 B USD
2084
ABSI
Absci Corporation - Common Stock
9.67 USD-4.82%-17.84%+20.42%+172.39%1.66 B USD
2125
STOK
Stoke Therapeutics, Inc. - Common Stock
24.15 USD-2.38%-5.59%-17.80%-20.48%1.56 B USD

Notizie